Furthermore, CRISPR/Cas9-mediated knockouts of WDR59 in various cancer cell lines, including HeLa and SUM159, resulted in reduced TORC1 signaling and growth inhibition [23,28,29,30,31]. The gene discussed is CRTC1; the disease is cancer.